Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 1804-1808, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greim, H.
Right arrow Articles by Werner, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greim, H.
Right arrow Articles by Werner, S.

Clinical Chemistry, Vol 41, 1804-1808, Copyright © 1995 by American Association for Clinical Chemistry

Biomarkers as tools in human health risk assessment

H Greim, G Csanady, JG Filser, P Kreuzer, L Schwarz, T Wolff and S Werner
Institut fur Toxikologie, GSF-Forschungszentrum fur Umwelt und Gesundheit, GmbH, Oberschleissheim, Germany.

Evaluation of occupational or environmental risk due to exposure to chemicals requires sufficient information on the toxic profiles, mechanisms of action, toxicokinetics, dose-response relation, exposure, and the target dose. Usually exposure is estimated by measuring concentrations of the agent in air, food, water, soil, dust, or other media with which a population or an individual is in contact. However, this external exposure is only a rough estimate for the internal exposure (agent dose or its metabolite at the critical target in the organism). Factors of influence are bioavailability of the chemicals, variations in concentrations and routes of exposure, physical activity, and individual variation in rates of metabolism, distribution, and excretion. All these affect the concentration of the toxic agent at the critical target, which is the most precise information for risk assessment. Thus, internal exposure is best measured by determining the concentration of the toxicant or its ultimate metabolite at the critical site in the target organ or by determining adducts with cellular macromolecules such as proteins, amino acids, DNA, or its bases. The latter are easily available in experimental toxicology from animal experiments but only occasionally from humans. For health surveillance such data usually are not available, because they require invasive procedures such as biopsies. Therefore, more accessible body fluids or tissue are used, such as blood, urine, or adipose tissue, or adducts with macromolecules such as albumin or hemoglobin in the blood, DNA adducts in peripheral lymphocytes, or altered DNA bases in urine such as 8-hydroxyguanine. All of these are indicators for exposure, whereas risk can only be estimated if the correlation between their deviations from normal and the dose-response at the critical target is known.


The following articles in journals at HighWire Press have cited this article:


Home page
 ANN OCCUP HYGHome page
E. McCANLIES, D. P. LANDSITTEL, B. YUCESOY, V. VALLYATHAN, M. L. LUSTER, and D. S. SHARP
Significance of Genetic Information in Risk Assessment and Individual Classification Using Silicosis as a Case Model
Ann. Hyg., June 1, 2002; 46(4): 375 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Sugimura, T. Kohno, K. Wakai, K. Nagura, K. Genka, H. Igarashi, B. J. Morris, S. Baba, Y. Ohno, C. Gao, et al.
hOGG1 Ser326Cys Polymorphism and Lung Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 669 - 674.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.